4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
gptkb:THIP
Gaboxadol |
| gptkbp:CASNumber |
85119-19-9
|
| gptkbp:drugClass |
GABAA receptor agonist
|
| gptkbp:hasInChIKey |
QXJYYZQXAFYFJA-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C6H8N2O2
|
| gptkbp:hasSMILES |
C1CC2=C(CNC1)ON=C2O
|
| https://www.w3.org/2000/01/rdf-schema#label |
4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol
|
| gptkbp:IUPACName |
4,5,6,7-tetrahydro-1,2-oxazolo[5,4-c]pyridin-3-ol
|
| gptkbp:meltingPoint |
>300°C
|
| gptkbp:PubChem_CID |
3475
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
benzodiazepine
sedative investigational drug anticonvulsant hypnotic |
| gptkbp:was_developed_by |
gptkb:Lundbeck
|
| gptkbp:was_withdrawn_from_market |
yes
|
| gptkbp:bfsParent |
gptkb:THIP
|
| gptkbp:bfsLayer |
7
|